Membrive-Jiménez, C.; Pérez-RamÃrez, C.; Arias-Santiago, S.; Richetta, A.G.; Ottini, L.; Pineda-Lancheros, L.E.; RamÃrez-Tortosa, M.d.C.; Jiménez-Morales, A.
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis. Int. J. Mol. Sci. 2023, 24, 8703.
https://doi.org/10.3390/ijms24108703
AMA Style
Membrive-Jiménez C, Pérez-RamÃrez C, Arias-Santiago S, Richetta AG, Ottini L, Pineda-Lancheros LE, RamÃrez-Tortosa MdC, Jiménez-Morales A.
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis. International Journal of Molecular Sciences. 2023; 24(10):8703.
https://doi.org/10.3390/ijms24108703
Chicago/Turabian Style
Membrive-Jiménez, Cristina, Cristina Pérez-RamÃrez, Salvador Arias-Santiago, Antonio Giovanni Richetta, Laura Ottini, Laura Elena Pineda-Lancheros, Maria del Carmen RamÃrez-Tortosa, and Alberto Jiménez-Morales.
2023. "Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis" International Journal of Molecular Sciences 24, no. 10: 8703.
https://doi.org/10.3390/ijms24108703
APA Style
Membrive-Jiménez, C., Pérez-RamÃrez, C., Arias-Santiago, S., Richetta, A. G., Ottini, L., Pineda-Lancheros, L. E., RamÃrez-Tortosa, M. d. C., & Jiménez-Morales, A.
(2023). Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis. International Journal of Molecular Sciences, 24(10), 8703.
https://doi.org/10.3390/ijms24108703